FLORHAM PARK, N.J., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that James Caruso, president and CEO, will present a company overview at the following upcoming conference: Oppenheimer Fall Healthcare Life Sciences & MedTech SummitPresentation Date:Monday, September 20, 2021Presentation Time:12:25PM Eastern TimeWebcast Li
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Ault Global The Trade: Ault Global Holdings, Inc. (NYSE: DPW) Executive Chairman Milton C. Ault III acquired a total of 50
If you've been meaning to invest in penny stocks and learn more about technical analysis, there's no better time than now.